An intensified BC surveillance program is recommended depending on patients’ age, morbidity, and personal preferences, even when individuals test negative for BRCA1 or 2 mutations if the family history indicates a “high risk” for BC through pedigree analysis [5]. The gene discussed is BRCA1; the disease is breast cancer.